Navigation Links
More Accurate "PROSTATE CANCER" Test can save Unnecessary Biopsies,,

Prostate cancer can effect men over the age of 40 years and is the second commonest cancer among men after lung cancer. Usually it goes undetected till it is advanced and beyond cure. However a lot of awareness has been created about this condition and now men over the age of 40 years can be screened regularly to detect the cancer.

One of the most promising "tumour markers" in medicine was developed over a decade ago to detect prostate cancer and is called "Prostate Specific Antigen" blood test or PSA for short. This test measures protein in the blood produced by the prostate gland and the normal level is between zero to four. Usually levels that are greater then 10 indicate cancer. However there are men in the "gray zone" whose PSA can be between 4 and 10. These men need biopsies to confirm thecancer.

Now a new test, called a "Free PSA" has further improved the diagnostic ability to detect the cancer and save almost 75% of the patients an unnecessary biopsy of the gland. PSA exists in blood as either being bound to protein or some of it floats around freely. This free form of PSA is key to identifying the patient who requires a biopsy.

Jean deKernion-Urologist, at the UCLA School of Medicine says, "A lot of people have a high PSA and don't have cancer. The free PSA helps you discern those people from the people who do have cancer. Free" PSA levels are lower in men with cancer than in those without. The test catches 95 percent of cancers while sparing men without the disease painful, expensive biopsies".
'"/>




Page: 1

Related medicine news :

1. DNA Testing For More Accurate Results
2. New Heart-Screening Device ,An Accurate Predictor Of Heart Disease
3. CT Scans Said to Accurately Detect Small Cancers
4. Can Men Gauge Biological Paternity Accurately
5. Women Read Men’s Faces Quite Accuratel
6. Bipolar Disorder Not Being Accurately Diagnosed By Doctors In UK
7. High Resolution CT Accurately Diagnoses Shin Splints
8. Automated Technique Accurately Measures Platelet Counts in "Platelet Gel" Products
9. Scientists Have Developed Faster, More Accurate TB Test
10. Depression Symptoms Less Likely in Kids with Accurate Self-Perceptions
11. New Tests Promise Rapid and Accurate Detection of Malaria
Post Your Comments:
(Date:7/9/2008)..., Barcelona, Spain: New figures on assisted repro... has been an explosion in the use of ICSI (intracy...he 24th annual meeting of the European Society of ...lona heard today (Wednesday). Researchers believe ... too often. , In 2005 the most recent year for ...
(Date:7/8/2008)..., Alexandria, Va.A study conducted in Sweden foun...untry whose wives died from cancer four or five ye...hat their spouse,s cancer was incurable, or they h...life. Eighty-six percent of widowers believed next...ancer is incurable, including 71 percent of the me...
(Date:7/8/2008)... CHICAGO, July 8 /PRNewswire/ -- Last month th...e Improvements for Patient and Providers Act",(H.R...re payments to,physicians and other providers went...ent relationship in great jeopardy., , To view t...ewswire.com/mnr/osteopathic/33934/ , The American...
(Date:7/8/2008)... Heart Failure Study Validates Use of Pharos In...ing Platform to Reduce Healthcare Utilization and ...IELD, Ill., July 8 /PRNewswire/ -- Pharos Innovati...t generation clinical and financial,performance im...platform,announced today the results from the Iow...
Breaking Medicine News(10 mins):Health News:Researcher say that ICSI may be over-used in some countries 2Health News:Researcher say that ICSI may be over-used in some countries 3Health News:Study finds that significant proportion of men told wife's cancer was incurable late or not at all 2Health News:Audio: Medicare Cuts Threaten Access to Health Care for Seniors 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 3
...ise that constant stress can make people sick, and...study focused on 119 men and women who were taking...caregivers was compared with that of 106 people of...e stress of constant care giving. Blood tests show...
...investigators more than 10 million children worldw...nd many of them preventable with existing medical ...these nations has dropped over the past half centu...f of the deaths in children under 5 take place in ...
...le who are bitten by animals poses little problem ... another human? That’s the question researchers se...onth’s Otolaryngology -- Head and Neck Surgery. Th...ords in Galveston, Texas, identified several key a...
... that early detection is important for preventing ...be as easy as mirrors with no tricks, just light.J...e’s lucky doctors were able to treat him despite a...ound a primary, which is what you call the skin ca...
Other Medicine News:
(Date:7/8/2008)...RNewswire/ -- Avir Green Hills Biotechnology,start...cine deltaFLU,against pandemic influenza. This nov...n the deletion of the NS1 gene has shown superior,...e biotech company sets,yet another milestone in th...m of Phase I Study, The randomized, double-blind ...
(Date:7/8/2008).../- After meeting on July 1st and,2nd ...betes drugs should,undergo trials to rule out card...f US endocrinologists agree with this recommendati...diovascular and metabolic primary market,research ...obal Life,Sciences Industry., On July 3rd AlphaDe...
(Date:7/8/2008)...eets primary endpoints in ENGAGE Trial, KENILWORT...-Plough,Corp., (NYSE: SGP ) announced today that ...follicle stimulant (SFS) met its primary endpoints...presented during a,Schering-Plough-sponsored sympo...ciety of Human Reproduction and Embryology (ESHRE)...
(Date:7/7/2008)...proves Cognition and is Well Tolerated in ...ndings Warrant Further Development in Huntington,s...Today at 5:00 p.m. EDT -, SAN FRANCISCO, July 7 /... MDVN ) today announced top-line results of a Pha...imebon(TM) significantly improved cognitive,functi...
Breaking Medicine Technology:Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU 2Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU 3AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panel's Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications. 2Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant 2Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant 3Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 2Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 3Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 4Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 5UCR plant cell biologist to study how plant stem cells maintain and change their identity 297 1UCR plant cell biologist to study how plant stem cells maintain and change their identity 297 2Prime Therapeutics Receives TIPPS Certification 729 1Prime Therapeutics Receives TIPPS Certification 729 2Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences 727 1Standard Management Announces OTCBB Listing 725 1Standard Management Announces OTCBB Listing 725 2
...FIELD, Mass.--(BUSINESS WIRE)--Jul 6, 2007 - Busin...race by pharmaceutical and,biotechnology companies...genesis treatment for cardiovascular disease. Whil...fi-Aventis, Boston,Scientific, Baxter, and Genzyme...ising new biological therapy for advanced,coronary...
...DGEWATER, N.J., July 05, 2007 /PRNewswire/ -- Resu...trolled, open-label, Phase,3 study showed that 77 ...ults taking PREZISTA(TM) (darunavir) 600 mg tablet...plus an optimized,background regimen (OBR) of anti...ad of <400 copies/mL at week 48, compared to 68,pe...
Other Medicine Technology:BusinessWeek Article Highlights Promising Breakthrough Treatment,for Advanced Coronary Artery Disease 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8
Titanium. Curved 18 mm shafts with 1.5 wide grasping tip. Flat, serrated cross action handle with dull finish.
Titanium. Designed to easily fold the hydroview lens. Will also fold many styles of soft intraocular lenses. Unique cross-action design facilitates folding of the lens.
30 degree angled tip with 45 mm tip opening. Stainless.
Insertion forcep used for the Hydroview lens. Manufactured in titanium.
Medicine Products: